Advertisement
Diagnostics
Subscribe to Diagnostics
View Sample

FREE Email Newsletter

SuperNova Diagnostics® to Present at Biotech Showcase™ 2011 During J.P. Morgan Healthcare Conference January 10-13

January 5, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, LONDON and HONG KONG, Jan. 5, 2011 /- SuperNova Diagnostics®, Inc., a privately-held global diagnostics company for human and non-human health applications, announced today that Neil J. Campbell, president and CEO, will present at Biotech Showcase 2011 in conjunction with...

Helena Laboratories to Manage BIS and OFAC Screening via ATTUS WatchDOG® Pro

January 5, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

CHARLOTTE, N.C., Jan. 5, 2011 /- ATTUS Technologies, Inc , adds Helena Laboratories, a clinical laboratory instrument and reagent manufacturer, to the growing list of global companies choosing the market leading WatchDOG® Pro for their BIS, OFAC and other watch list screening...

Elekta's MOSAIQ Oncology Information System Named Category Leader in '2010 Top 20 Best in KLAS Awards' Report

January 5, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

ATLANTA, Jan. 5, 2011 /- Elekta's MOSAIQ® Oncology Information System (OIS)—the market's leading open-system, vendor-neutral OIS—has earned the No. 1 ranking in the oncology software category from KLAS, an independent research firm. According to KLAS, a Category Leader...

Advertisement

Estrogen May Help Precancerous Cells Spread in Oral Cavity

January 5, 2011 5:33 am | by AACR | News | Comments

PHILADELPHIA - Head and neck cancer is the sixth most common type of cancer and is on the rise in some demographic groups, including young women without any known risk factors. Now, researchers at Fox Chase Cancer Center report that estrogen may increase the movement of precancerous cells...

Endo to Present at the J.P. Morgan 29th Annual Healthcare Conference

January 4, 2011 7:33 am | by Bio-Medicine.Org | News | Comments

CHADDS FORD, Pa., Jan. 4, 2011 /- Endo Pharmaceuticals (Nasdaq: ENDP ) today announced that it will present at the J.P. Morgan 29th Annual Healthcare Conference on Monday, January 10, 2011 at 1:30 p.m. PT.  David P. Holveck, president and CEO of Endo, will review the company's...

GE Healthcare, Beckman Coulter, Boston Scientific, Purdue University, University of Illinois present engineering innovations at MEDCon

January 4, 2011 5:46 am | News | Comments

Medical Electronic Device Conference & Expo (MEDCon) will be held May 16-18, 2011 at Navy Pier in Chicago, IL.  This event provides the opportunity to stay at the forefront of innovations in engineering for electronic medical devices.

PositiveID Corporation and Siemens AG Enter Into Agreement to Expand PositiveID's Wireless Body Platform

January 4, 2011 4:34 am | by PositiveID | News | Comments

Siemens' Intellectual Property to Broaden Applications to Improve Disease Management

Nationwide Launch of Arstasis One Access Device Provides Cath Labs Across the U.S. an Alternative to Standard Arteriotomies and Vascular Closure Implants

January 4, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

REDWOOD CITY, Calif., Jan. 4, 2011 /- Arstasis is pleased to announce the Arstasis One Access Device is available to physicians, nurses, patients, and cath lab technicians across the United States.  Until now, only a select number of physicians participating in Arstasis clinical...

Advertisement

Graymark Healthcare's Sleep Apnea Therapy Program Services Record Number of Patients in Q4 2010

January 4, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

OKLAHOMA CITY, Jan. 4, 2011 /- Graymark Healthcare Inc. (Nasdaq: GRMH ), the nation's second largest provider of diagnostic sleep services and an innovator in comprehensive care for obstructive sleep apnea (OSA), serviced a record number of OSA patients in the fourth quarter of 2010, with...

Medicare payments for medical imaging are higher to nonradiologist physicians than to radiologists

January 3, 2011 8:33 pm | by EurekAlert | News | Comments

(American College of Radiology / American Roentgen Ray Society) Researchers have found that Medicare payments for non-invasive medical imaging, including magnetic resonance imaging and computed tomography scans, are now higher to non-radiologists than to radiologists, according to a study...

Veridex, LLC Announces Collaboration to Develop Next-Generation Circulating Tumor Cell (CTC) Technology with Massachusetts General Hospital

January 3, 2011 4:32 am | by Bio-Medicine.Org | News | Comments

RARITAN, N.J., Jan. 3, 2011 /- Veridex, LLC (Veridex) today announced a collaboration with Massachusetts General Hospital to develop and commercialize a next-generation circulating tumor cell (CTC) technology for capturing, counting and characterizing tumor cells found in patients'...

InstaCare Corp. to Announce Guidance on Its Genstrip Product Line on January 10, 2011

December 30, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Dec. 30, 2010 /- InstaCare Corp. (OTC Bulletin Board: ISCR ),  the exclusive distributor of the Shasta Genstrip diagnostic testing strips, a leading provider of prescription and non-prescription diagnostics, home testing products for the chronically ill, as well as leading...

Dr. Marianne T. Sweetser Recognized by Strathmore's Who's Who Worldwide Publication

December 30, 2010 4:33 am | by Bio-Medicine.Org | News | Comments

SYOSSET, N.Y., Dec. 30, 2010 /- Dr. Marianne T. Sweetser, of Cambridge, Massachusetts, has been included in the Strathmore's Who's Who Worldwide Edition for her outstanding contributions and achievements in the field of biopharmaceuticals. ABOUT DR. MARIANNE T. SWEETSER Dr. Sweetser...

Advertisement

Stereotaxis Announces Global Initial Training Site at University of Chicago

December 30, 2010 4:32 am | by Bio-Medicine.Org | News | Comments

ST. LOUIS, Dec. 30, 2010 /- Stereotaxis, Inc. (Nasdaq: STXS ) announced today that starting in 2011, Stereotaxis will utilize the Remote Magnetic Navigation System in the electrophysiology (EP) lab at the University of Chicago Medical Center to train clinicians planning to install...

Reportlinker Adds Women's Health Diagnostic Testing

December 29, 2010 7:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Dec. 29, 2010 /- Reportlinker.com announces that a new market research report is available in its catalogue: Women's Health Diagnostic Testing http://www.reportlinker.com/p0357030/Women's-Health-Diagnostic-Testing.html The purpose of this TriMark Publications report is to...

Pfizer Animal Health to Acquire Synbiotics Corporation, Entering Diagnostics Sector

December 29, 2010 7:33 am | by Bio-Medicine.Org | News | Comments

MADISON, N.J., Dec. 29, 2010 /- Pfizer Animal Health today announced an agreement to acquire Synbiotics Corporation (Pink Sheets: SYNB ), a privately held, Kansas City-based leader in the development, manufacture and marketing of immunodiagnostic tests for companion and food production...

New imaging disclosure requirements could mean opportunity for radiologists

December 29, 2010 6:34 am | by Diagnostic Imaging | News | Comments

Starting January 1st, referring physicians who provide in-office imaging services must provide their patients with a list of other options in their area. It's probably a good time to make sure your practice is on that list.

Reportlinker Adds Over-the-Counter Diagnostic Products World Markets

December 29, 2010 6:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Dec. 29, 2010 /- Reportlinker.com announces that a new market research report is available in its catalogue: Over-the-Counter Diagnostic Products World Markets http://www.reportlinker.com/p024985/Over-the-Counter-Diagnostic-Products-World-Markets.html The purpose of this TriMark...

Reportlinker Adds Molecular Diagnostics in Cancer Testing

December 29, 2010 6:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Dec. 29, 2010 /- Reportlinker.com announces that a new market research report is available in its catalogue: Molecular Diagnostics in Cancer Testing http://www.reportlinker.com/p0171427/Molecular-Diagnostics-in-Cancer-Testing.html Molecular diagnostics is a rapidly-advancing...

Reportlinker Adds Mammography World Markets

December 29, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Dec. 29, 2010 /- Reportlinker.com announces that a new market research report is available in its catalogue: Mammography World Markets http://www.reportlinker.com/p098222/Mammography-World-Markets.html The women's mammography segment is poised for a major new phase of growth...

Purdue, NIST working on breathalyzers for medical diagnostics

December 28, 2010 8:33 am | by EurekAlert | News | Comments

(Purdue University) Researchers have overcome a fundamental obstacle in developing breath-analysis technology to rapidly diagnose patients by detecting chemical compounds called "biomarkers" in a person's respiration in real time.

Mindray Medical Announces Shareholder Resolutions Adopted at 2010 Annual General Meeting

December 27, 2010 4:34 am | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, Dec. 27, 2010 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR ), a leading developer, manufacturer and marketer of medical devices worldwide, today announced shareholder resolutions adopted at its annual general meeting of shareholders held...

Cepheid Announces European Release of Xpert Flu, Delivering Simultaneous Detection and Differentiation of Flu A, Flu B, and 2009 H1N1 Strain

December 27, 2010 2:32 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Dec. 27, 2010 /- Cepheid (Nasdaq: CPHD ) today announced the release of Xpert® Flu as a European CE IVD Mark product under the European Directive on In Vitro Diagnostic Medical Devices. The test, which runs on Cepheid's GeneXpert® System, simultaneously...

Newborns with low vitamin D levels at increased risk for respiratory infections

December 26, 2010 8:32 pm | by EurekAlert | News | Comments

(Massachusetts General Hospital) The vitamin D levels of newborn babies appear to predict their risk of respiratory infections during infancy and the occurrence of wheezing during early childhood, but not the risk of developing asthma.

PTC Therapeutics Completes Enrollment of Phase 3 Trial of Ataluren in Patients with Cystic Fibrosis

December 21, 2010 5:30 am | by Bio-Medicine.Org | News | Comments

SOUTH PLAINFIELD, N.J., Dec. 21, 2010 /- PTC Therapeutics, Inc. announced today that it has completed enrollment of a Phase 3 clinical trial of ataluren, an investigational new drug, in patients with nonsense mutation cystic fibrosis (nmCF). (Logo:...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading